Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

BioExx Specialty Proteins Ltd BIXZF

"Bioexx Specialty Proteins Inc is engaged in the development and commercialization of processing technologies, for use in the extracting various active ingredients from organic and inorganic materials. The company's primary focus is on the production of proteins from canola and other oilseed feedstocks. Its products include Isolexx, a protein isolate for use in bakery products, meat products, vegetarian food products and meat analogues, and nutritional and protein bars, drinks, and supplements;


GREY:BIXZF - Post by User

Post by TSX-BEARon Jun 30, 2013 9:29pm
196 Views
Post# 21582324

How do you explain this....

How do you explain this....There is  FDA gras approval in the USA and a signed deal from July 2011 with Hormel Century Foods for Isolexx protein isolates and a plant in Ssakatoon near the border of NorthDakota where another plant was in the works yet the only interest has been from Europe where they have to wait for EFSA approval. It come out at the AGM that they were approached by European entity.

Can anyone explain why there is such a discrepancy in these incongruous situations whereby a starter  plant has to be sold to pay debt in a North American continent with 300 million population and an approved product only to hope that the EU gets approval while there is a looming cash crunch ?

What am I missing ?
<< Previous
Bullboard Posts
Next >>